Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Verinder Sharma
Age
18–45
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Outpatient woman between ages 18 - 45
Within 6 months of delivery
Have a DSM-5 diagnosis of MDD or BD I, BD II or other specified bipolar or related disorder with peripartum onset
Have a score of \>18 on the 17-item Hamilton Depression Rating Scale (HDRS)
Have a score of ≤12 Young Mania Rating Scale (YMRS) at both the screening and baseline visits
Able to communicate in English
Capable of providing informed consent
You may not be if
A diagnosis of schizophrenia spectrum or other psychotic disorders, obsessive-compulsive disorder, eating disorders, substance-related and addictive disorders
At high risk for suicide (actively suicidal or a score of ≥ 3 on item #3 on the HDRS)
Receiving a psychotropic drug such a mood stabilizer, an antidepressant or a sedative/hypnotic.
Receiving psychotherapy
Have a physical illness that is a contraindication to the use of quetiapine, or who have a history of intolerance or nonresponse to quetiapine
Pregnant or planning on becoming pregnant during the study
Clareo Health | The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression
